兰国钰博士,中山大学医学院副教授,博士生导师。2013-2021年就读于北京大学医学部,获得学士和博士学位,随后在深圳湾实验室完成博士后及副研究员工作,2026年3月全职加入中山大学医学院开展独立科研工作。主要从事阿尔茨海默病、帕金森病的生物标志物和发病机制研究,以第一作者或通讯作者 (含共同) 在Nat. Aging, Cell Rep Med., Alzheimers Dement,Mol. Psychiatry,J Prev Alzheimers Dis, Ann. Neurol, Transl. Neurodegeneration, Glia等杂志发表多篇研究论文。主持国家自然科学基金青年基金项目C类、中国博士后科学基金特别资助(站中)以及深圳医学研究专项青年项目。
主要研究方向:
- 阿尔茨海默病、帕金森病等神经退行性疾病的新型体液生物标志物开发。
- 基于人群队列探究阿尔茨海默病的临床病理演化特征及早期诊断。
- 阿尔茨海默病的神经生物学机制。
课题组长期招收硕士生、博士生、博士后,欢迎具有神经科学、生物信息学等交叉学科背景的同学加入。
教育经历:
(1) 2018-09 至 2021-07,北京大学医学部,病理学,博士
(2) 2013-09 至 2018-07,北京大学医学部,基础医学,学士
工作经历:
(1) 2026-03至今,中山大学医学院,副教授
(2) 2025-06至2026-03,深圳湾实验室,神经疾病研究所,副研究员
(3) 2024-02至 2025-05,深圳湾实验室,神经疾病研究所,助理研究员
(4) 2021-08至 2024-01,深圳湾实验室,生物医学工程研究所,博士后
代表性成果(#共同第一作者; *共同通讯作者):
- Xuhui Chen#; Mingxing Jiang#; Laihong Zhang;…Tengfei Guo*; Yongan Sun*; Guoyu Lan*. Association of plasma p-tau and p-tau/Aβ ratio with Alzheimer’s pathology, The Journal of Prevention of Alzheimer’s Disease, 2026.
- Guoyu Lan#; Mengjie Wang#; Fernando Gonzalez-Ortiz#;Laihong Zhang#; …Tengfei Guo. Comprehensive Evaluation of Plasma Tau Biomarkers for Detecting and Monitoring Alzheimer's Disease in a Multicenter and Multiethnic Aging Population, Nature Aging, 2025.
- Guoyu Lan#; Binyin Li#; Mengjie Wang; …Tengfei Guo. Plasma growth-associated protein 43 correlates with synaptic loss in Alzheimer’s disease, Cell Reports Medicine, 2025.
- Guoyu Lan; Laihong Zhang; Anqi Li; …Tengfei Guo. Plasma N-terminal tau fragment is an amyloid-dependent biomarker in Alzheimer’s disease, Alzheimer's & Dementia, 2025,21(3):e14550.
- Guoyu Lan#; Anqi Li#; Fernando Gonzalez-Ortiz; …Tengfei Guo. Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer’s disease, Molecular Psychiatry, 2025.
- Jun Wang#; Shan Huang#; Guoyu Lan#; ... Tengfei Guo; Yanjiang Wang. Diagnostic accuracy of plasma p-tau217/Aβ42 for Alzheimer’s disease in clinical and community cohorts, Alzheimer's & Dementia, 2025,21(3):e70038.
- Guoyu Lan; Xuhui Chen;Jie Yang;…Tengfei Guo.Microglial reactivity correlates to presynaptic loss independent of β-amyloid and tau, Annals of Neurology, 2024,95(5):917-928.
- Guoyu Lan; Anqi Li; Zhen Liu; …Tengfei Guo; Alzheimer's Disease NeuroimagingInitiative. Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline, Alzheimer's & Dementia, 2023,19(6):2408-2419.
- Pan Wang#; Guoyu Lan#; Bin Xu; …Jing Zhang. α-Synuclein-carrying Astrocytic Extracellular Vesicles in Parkinson Pathogenesis and Diagnosis, Translational Neurodegeneration, 2023,12(1):40.
- Guoyu Lan; Jing Du; Xuhui Chen; …Tengfei Guo. Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline, Neurobiology of Aging, 2023,132:209-219.
- Guoyu Lan; Yue Cai; Anqi Li; …Tengfei Guo. Association of Presynaptic Loss with Alzheimer’s Disease and Cognitive Decline, Annals of Neurology, 2022,92(6):1001-1015.
- Guoyu Lan; Pan Wang; Zongran Liu; …Jing Zhang. Astrocytic VEGFA: An Essential Mediator in Blood-brain-barrier Disruption in Parkinson’s disease, Glia, 2022,70(2):337-353.


